REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,885,744 | -79.3% | 6,052,000 | -72.9% | 0.32% | -78.0% |
Q2 2023 | $23,575,535 | +10.4% | 22,325,000 | +28.9% | 1.46% | +3.5% |
Q1 2023 | $21,353,288 | +2076.1% | 17,325,000 | +1529.8% | 1.41% | +2416.1% |
Q4 2022 | $981,248 | -67.2% | 1,063,000 | -61.3% | 0.06% | -60.3% |
Q3 2022 | $2,992,000 | – | 2,750,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |